Showing results (1271-1280 of 1,568) with videos related to

Sort By:
Pageof 157
Advances in Radiation Oncology|March 2, 2026
Comparison of 3 vs 5 Fraction Single Isocenter Radiosurgery for Brain MetastasesLuke A Moradi, Richard A Popple, Roman L Travis, et al.
Pregnancy Hypertension|June 25, 2015
PP124. Trofoblastic invasion: The role of subunits STAT1 and STAT3H M F Marconato, V J A Panico, L Saragiotto, et al.
Environmental Microbiology|July 5, 2019
Characterization of a thaumarchaeal symbiont that drives incomplete nitrification in the tropical sponge Ianthella bastaFlorian U Moeller, Nicole S Webster, Craig W Herbold, et al.
Theranostics|January 9, 2026
Quantitative dynamic granzyme B PET imaging to characterize novel combination immunotherapy response in preclinical glioblastoma modelsCarlos A Gallegos, Yun Lu, Patrick N Song, et al.
Bioorganic & Medicinal Chemistry Letters|June 27, 2015
Design, synthesis and evaluation of MCH receptor 1 antagonists--Part I: Optimization of HTS hits towards an in vivo efficacious tool compound BI 414Stephan G Müller, Armin Heckel, Jörg T Kley, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 27, 2019
Repeat gamma knife stereotactic radiosurgery in the treatment of trigeminal neuralgia: A single-center experience and focused review of the literatureN B Omar, J W Amburgy, D M Self, et al.
Scientific Reports|September 19, 2018
Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 ExpressionGregory K Friedman, Joshua D Bernstock, Dongquan Chen, et al.
Cell Metabolism|March 29, 2025
Intermittent fasting boosts sexual behavior by limiting the central availability of tryptophan and serotoninKan Xie, Chengfeng Wang, Enzo Scifo, et al.
The Journal of Allergy and Clinical Immunology|August 18, 2009
Comèl-Netherton syndrome defined as primary immunodeficiencyEllen D Renner, Dominik Hartl, Stacey Rylaarsdam, et al.
Human Gene Therapy|July 14, 2020
Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain TumorsJoshua D Bernstock, Asim K Bag, John Fiveash, et al.
Pageof 157